Salivary metabolic signatures of carotid atherosclerosis in patients with type 2 diabetes hospitalized for treatment.

MLA

Sakanaka, Akito, et al. “Salivary Metabolic Signatures of Carotid Atherosclerosis in Patients with Type 2 Diabetes Hospitalized for Treatment.” Frontiers in Molecular Biosciences, vol. 9, Dec. 2022, p. 1074285. EBSCOhost, https://doi.org/10.3389/fmolb.2022.1074285.

APA

Sakanaka, A., Katakami, N., Furuno, M., Nishizawa, H., Omori, K., Taya, N., Ishikawa, A., Mayumi, S., Inoue, M., Tanaka Isomura, E., Amano, A., Shimomura, I., Fukusaki, E., & Kuboniwa, M. (2022). Salivary metabolic signatures of carotid atherosclerosis in patients with type 2 diabetes hospitalized for treatment. Frontiers in Molecular Biosciences, 9, 1074285. https://doi.org/10.3389/fmolb.2022.1074285

Chicago

Sakanaka, Akito, Naoto Katakami, Masahiro Furuno, Hitoshi Nishizawa, Kazuo Omori, Naohiro Taya, Asuka Ishikawa, et al. 2022. “Salivary Metabolic Signatures of Carotid Atherosclerosis in Patients with Type 2 Diabetes Hospitalized for Treatment.” Frontiers in Molecular Biosciences 9 (December): 1074285. doi:10.3389/fmolb.2022.1074285.